News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,715 Results
Type
Article (40429)
Company Profile (253)
Press Release (661033)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204955)
Career Advice (2024)
Deals (35470)
Drug Delivery (96)
Drug Development (81191)
Employer Resources (172)
FDA (16219)
Job Trends (14921)
News (346265)
Policy (32637)
Tag
Academia (2600)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49728)
ALS (88)
Alzheimer's disease (1380)
Antibody-drug conjugate (ADC) (124)
Approvals (16224)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (362)
Best Places to Work (11664)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2251)
Cardiovascular disease (173)
Career advice (1689)
Career pathing (31)
CAR-T (151)
Cell therapy (422)
Cervical cancer (19)
Clinical research (66065)
Collaboration (833)
Compensation (524)
Complete response letters (19)
COVID-19 (2603)
CRISPR (40)
C-suite (242)
Cystic fibrosis (100)
Data (2196)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (270)
Diagnostics (6395)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86690)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112752)
Executive appointments (724)
FDA (17465)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (753)
Gene editing (104)
Generative AI (19)
Gene therapy (302)
GLP-1 (707)
Government (4440)
Grass and pollen (4)
Guidances (59)
Healthcare (18846)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2746)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (314)
IPO (16523)
IRA (40)
Job creations (3667)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (18)
Legal (7926)
Liver cancer (76)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13407)
Medtech (13412)
Mergers & acquisitions (19488)
Metabolic disorders (683)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1914)
NextGen: Class of 2025 (6532)
Non-profit (4509)
Now hiring (39)
Obesity (362)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57598)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20605)
Phase II (29087)
Phase III (21664)
Pipeline (1185)
Policy (139)
Postmarket research (2568)
Preclinical (8768)
Press Release (68)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5968)
Recruiting (65)
Regulatory (22332)
Reports (46)
Research institute (2361)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (130)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3600)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (173)
Last 7 days (870)
Last 30 days (2629)
Last 365 days (32868)
2025 (10617)
2024 (35264)
2023 (40140)
2022 (51244)
2021 (55810)
2020 (54207)
2019 (46687)
2018 (35176)
2017 (32279)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (722)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38071)
Australia (6221)
California (6106)
Canada (2009)
China (521)
Colorado (265)
Connecticut (272)
Delaware (147)
Europe (81742)
Florida (907)
Georgia (206)
Idaho (57)
Illinois (534)
India (25)
Indiana (306)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (889)
Massachusetts (4558)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1724)
New Mexico (28)
New York (1739)
North Carolina (965)
North Dakota (8)
Northern California (2668)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1372)
Puerto Rico (12)
Rhode Island (33)
South America (1105)
South Carolina (22)
South Dakota (1)
Southern California (2293)
Tennessee (102)
Texas (907)
United States (23050)
Utah (180)
Virginia (147)
Washington D.C. (61)
Washington State (551)
West Virginia (3)
Wisconsin (54)
701,715 Results for "clearside biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 28, 2025
·
11 min read
Press Releases
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 25, 2025
·
7 min read
Press Releases
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
March 21, 2025
·
7 min read
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Press Releases
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025
March 12, 2025
·
2 min read
Press Releases
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
February 21, 2025
·
6 min read
Press Releases
Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference
February 5, 2025
·
1 min read
Press Releases
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD
March 7, 2025
·
7 min read
BioMidwest
Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery
Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced plans to host a virtual key opinion leader event on Wednesday, July 24, 2024 from 8:00 - 9:15 am ET.
June 27, 2024
·
6 min read
1 of 70,172
Next
